Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pituitary incidentalomas].

Lucio Vilar1, Monalisa F Azevedo, Gilka Barisic

  • 1Unidade de Endocrinologia, Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, PE. lvilar@veloxmail.com.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D and thyroid function of pregnant women in a sunny region: is there any connection?

Revista da Associacao Medica Brasileira (1992)·2025
Same author

Parathyroid carcinoma and pheochromocytoma in a patient with neurofibromatosis type 1: a rare association.

Endocrinology, diabetes & metabolism case reports·2025
Same author

Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients.

Archives of endocrinology and metabolism·2024
Same author

"Micromegaly": Acromegaly with apparently normal GH, an entity on its own?

Best practice & research. Clinical endocrinology & metabolism·2024
Same author

Accuracy of the 10 μg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis.

Frontiers in endocrinology·2024
Same author

Germline loss-of-function <i>PAM</i> variants are enriched in subjects with pituitary hypersecretion.

Frontiers in endocrinology·2023
Same journal

PTPN2 gene polymorphisms are associated with type 1 diabetes mellitus in Brazilian subjects?

Arquivos brasileiros de endocrinologia e metabologia·2015
Same journal

PTPN2, a potential therapeutic target for type 1 diabetes?

Arquivos brasileiros de endocrinologia e metabologia·2015
Same journal

Response to the letter: Red cell distribution width in subclinical hypothyroidism.

Arquivos brasileiros de endocrinologia e metabologia·2015
Same journal

Red cell distribution width in subclinical hypothyroidism.

Arquivos brasileiros de endocrinologia e metabologia·2015
Same journal

Response to the letter: Angiotensin-II induced insulin resistance.

Arquivos brasileiros de endocrinologia e metabologia·2015
Same journal

Angiotensin-II induced insulin resistance.

Arquivos brasileiros de endocrinologia e metabologia·2015
See all related articles

Pituitary incidentalomas are common findings on MRI scans. Long-term follow-up is crucial for these lesions, as some may grow or become hormonally active, requiring intervention.

Area of Science:

  • Endocrinology
  • Radiology
  • Neurosurgery

Context:

  • Magnetic resonance imaging (MRI) reveals clinically unsuspected pituitary lesions in about 10% of adults.
  • These pituitary incidentalomas are typically small (<10 mm) and asymptomatic.
  • However, their natural history and potential for growth or hormonal activity require further understanding.

Purpose:

  • To review the natural history and management of pituitary incidentalomas.
  • To define indications for follow-up and therapeutic intervention.
  • To highlight the importance of monitoring lesions, especially those larger than 10 mm (macroincidentalomas).

Summary:

  • Pituitary incidentalomas are frequently detected via MRI.
  • While often benign, they can exhibit hormonal activity or mass effects.

Related Experiment Videos

  • Monitoring is essential, with interventions for growth, hormonal imbalance, or mass effects.

    • Impact:

    • Establishes the need for standardized follow-up protocols for pituitary incidentalomas.
    • Guides clinical decision-making regarding intervention versus observation.
    • Improves patient outcomes by addressing potential complications of pituitary incidentalomas early.